RxDoctor Payments Data

Dudley Phipps

Surgical · Des Moines, IANPI 1306807714

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $114,294 of the $172,548 with a category attached, or 66.2%. Amgen accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among surgical clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$172,548in general payments, 2019–2025

Across 365 payments — averaging $472.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$172K
  • AstraZeneca$119

What the payments were for

  • Consulting fees$3,7502%
  • Speaking & faculty fees$114,29466%
  • Travel & lodging$48,52428%
  • Food & beverage$5,9803%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen364$172,429
AstraZeneca1$119

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$172,548 in reported general payments places this provider in the 95th percentile of 49 surgical providers in Iowa.

See all surgical providers in Iowa

Other surgical in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →